The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Skill Stacking: How Micro-Credentials Are Reshaping Trades
Prima Medicine Opens New Location in Tysons, Virginia
Anchorage Neighborhood Health Center Ensnared in Cyberattack
Healthcare Real Estate: Responding to Shifting Patient Demands
Over 40% of Workers Impacted by Seasonal Depression